IU researchers receive grant to study potential new opioid addiction treatment

(Indiana University School of Medicine) Researchers at Indiana University School of Medicine are testing use of tezampanel, a novel antagonist at glutamate receptors that could treat opioid withdrawal syndrome and other addictions and mental illnesses. The school recently received a $12.3 million grant from the National Institute on Drug Abuse (NIDA) supporting a two-stage project for medication development.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news